Research & Literature

Uveitis associated with juvenile idiopathic arthritis.

Sen ES, Dick AD, Ramanan AV

Nature reviews. Rheumatology 2015; (11(6)):338-48 doi:10.1038/nrrheum.2015.20.

Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis.

Whitcup SM, Robinson MR

Annals of the New York Academy of Sciences 2015; (1358()):1-12 doi:10.1111/nyas.12824.

Acute Anterior Uveitis and Spondyloarthritis: More Than Meets the Eye.

Khan MA, Haroon M, Rosenbaum JT

Current rheumatology reports 2015; (17(9)):59 doi:10.1007/s11926-015-0536-x.

The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis.

Kothari S, Foster CS, Pistilli M, et al.

Ophthalmology 2015; (122(10)):1987-2001.

Noninfectious uveitis: strategies to optimize treatment compliance and adherence.

Dolz-Marco R, Gallego-Pinazo R, Díaz-Llopis M, et al.

Clinical ophthalmology (Auckland, N.Z.) 2015; (9()):1477-81 doi:10.2147/OPTH.S36650.

Patterns of uveitis at the Apex Institute for Eye Care in India: Results from a prospectively enrolled patient data base (2011-2013).

Venkatesh P, Gogia V, Shah B, et al.

International ophthalmology 2016; (36(3)):365-72 doi:10.1007/s10792-015-0128-9.

Vogt-Koyanagi-Harada syndrome and Crohn's disease: an exceptional association.

Souguir A, Hammami A, Dahmeni W, et al.

Gastroenterology report 2018; (6(1)):65-67 doi:10.1093/gastro/gov056.

Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.

Dick AD, Tundia N, Sorg R, et al.

Ophthalmology 2016; (123(3)):655-62.

Fulminant proliferative vitreoretinopathy in syphilitic uveitis.

Queiroz Rde P, Diniz AV, Vasconcelos-Santos DV

Journal of ophthalmic inflammation and infection 2016; (6(1)):6 doi:10.1186/s12348-016-0075-2.

Preventive effect of chrysin on experimental autoimmune uveitis triggered by injection of human IRBP peptide 1-20 in mice.

Meng X, Fang S, Zhang Z, et al.

Cellular & molecular immunology 2017; (14(8)):702-711 doi:10.1038/cmi.2015.107.

Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis.

Grajewski RS, Boelke AC, Adler W, et al.

Eye (London, England) 2016; (30(11)):1415-1423 doi:10.1038/eye.2016.133.

Review for Diagnostics of the Year: Multimodal Imaging in Behçet Uveitis.

Tugal-Tutkun I, Ozdal PC, Oray M, Onal S

Ocular immunology and inflammation 2017; (25(1)):7-19 doi:10.1080/09273948.2016.1205100.

Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.

de Winter JJ, van Mens LJ, van der Heijde D, et al.

Arthritis research & therapy 2016; (18()):196 doi:10.1186/s13075-016-1093-z.

Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.

Fabiani C, Vitale A, Emmi G, et al.

Clinical rheumatology 2017; (36(1)):183-189 doi:10.1007/s10067-016-3480-x.

LONG-TERM OUTCOMES OF RITUXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS POSTERIOR UVEITIS REFRACTORY TO CONVENTIONAL IMMUNOSUPPRESSIVE THERAPY.

Lasave AF, You C, Ma L, et al.

Retina (Philadelphia, Pa.) 2018; (38(2)):395-402 doi:10.1097/IAE.0000000000001563.

Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.

Daniel E, Pistilli M, Kothari S, et al.

Ophthalmology 2017; (124(8)):1196-1208 doi:10.1016/j.ophtha.2017.03.041.

Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis.

Shin YU, Shin JY, Ma DJ, et al.

Journal of ophthalmology 2017; (2017()):5946240 doi:10.1155/2017/5946240.

Ocular sarcoidosis: new diagnostic modalities and treatment.

Yang SJ, Salek S, Rosenbaum JT

Current opinion in pulmonary medicine 2017; (23(5)):458-467 doi:10.1097/MCP.0000000000000409.

Immunosuppression for the Uveitides.

Jabs DA

Ophthalmology 2018; (125(2)):193-202 doi:10.1016/j.ophtha.2017.08.007.

Ocular antigen does not cause disease unless presented in the context of inflammation.

Voigt V, Wikstrom ME, Kezic JM, et al.

Scientific reports 2017; (7(1)):14226 doi:10.1038/s41598-017-14618-z.

Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative.

Dick AD, Rosenbaum JT, Al-Dhibi HA, et al.

Ophthalmology 2018; (125(5)):757-773 doi:10.1016/j.ophtha.2017.11.017.

Autoimmunity in uveitis.

Ten Berge JC, Schreurs MWJ, van Daele PLA, Rothova A

Acta ophthalmologica 2018; (96(5)):481-485 doi:10.1111/aos.13652.

Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience.

Pohlmann D, Vom Brocke GA, Winterhalter S, et al.

Ophthalmology 2018; (125(7)):1088-1099 doi:10.1016/j.ophtha.2017.12.038.

Cytokines in uveitis.

Weinstein JE, Pepple KL

Current opinion in ophthalmology 2018; (29(3)):267-274 doi:10.1097/ICU.0000000000000466.

Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?

Mitulescu TC, Trandafir M, Dimăncescu MG, et al.

Romanian journal of ophthalmology 2018; (62(2)):114-122.

Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) - Report 2: Pattern of Uveitis Investigations in Singapore.

Low R, Chen EJ, Bin Ismail MA, et al.

Ocular immunology and inflammation 2020; (28(1)):92-99 doi:10.1080/09273948.2018.1535080.

Current Practices in Ocular Tuberculosis: A Survey of Brazilian Specialists.

Fernández Zamora Y, Finamor LP, Silva LMP, et al.

Ocular immunology and inflammation 2020; (28(2)):256-261 doi:10.1080/09273948.2018.1563705.

Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.

Rathinam SR, Gonzales JA, Thundikandy R, et al.

JAMA 2019; (322(10)):936-945 doi:10.1001/jama.2019.12618.

Resolution of uveitis.

Wildner G, Diedrichs-Möhring M

Seminars in immunopathology 2019; (41(6)):727-736 doi:10.1007/s00281-019-00758-z.

Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis

Hasanreisoğlu M, Özdemir HB, Özkan K, et al.

Turkish journal of ophthalmology 2019; (49(5)):250-257 doi:10.4274/tjo.galenos.2019.81594.

The Clinical Characteristics of Pediatric Non-Infectious Uveitis in Two Tertiary Referral Centers in Turkey.

Yalçındağ FN, Güngör SG, Değirmenci MFK, et al.

Ocular immunology and inflammation 2021; (29(2)):282-289 doi:10.1080/09273948.2019.1674890.

Ocular syphilis: case series (2000-2015) from 2 tertiary care centres in Montreal, Canada.

Vadboncoeur J, Labbé AC, Fortin C, et al.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2020; (55(1)):30-37 doi:10.1016/j.jcjo.2019.05.009.

Lessons of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement.

Auluck I, Karimi A, Taylor S

Clinical medicine (London, England) 2019; (19(6)):519-522 doi:10.7861/clinmed.2019.0149.

Optical coherence tomography angiography in uveitis.

Tranos P, Karasavvidou EM, Gkorou O, Pavesio C

Journal of ophthalmic inflammation and infection 2019; (9(1)):21 doi:10.1186/s12348-019-0190-y.

Phenotype of Innate Immune Cells in Uveitis Associated with Axial Spondyloarthritis- and Juvenile Idiopathic Arthritis-associated Uveitis.

Kasper M, Walscheid K, Laffer B, et al.

Ocular immunology and inflammation 2021; (29(6)):1080-1089 doi:10.1080/09273948.2020.1715449.

Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis.

Zhong Z, Su G, Kijlstra A, Yang P

Progress in retinal and eye research 2021; (80()):100866 doi:10.1016/j.preteyeres.2020.100866.

New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview.

Valenzuela RA, Flores I, Urrutia B, et al.

Frontiers in pharmacology 2020; (11()):655 doi:10.3389/fphar.2020.00655.

Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.

Jaffe GJ, Pavesio CE,

Ophthalmology 2020; (127(10)):1395-1404 doi:10.1016/j.ophtha.2020.04.001.

Functionally distinct IFN-γ+ IL-17A+ Th cells in experimental autoimmune uveitis: T-cell heterogeneity, migration, and steroid response.

Chen YH, Eskandarpour M, Gondrand A, et al.

European journal of immunology 2020; (50(12)):1941-1951 doi:10.1002/eji.202048616.

Recurrence Rates of Inflammation after Switching from the Originator Infliximab to Biosimilar Infliximab-abda for Noninfectious Uveitis.

Deaner JD, Srivastava SK, Hajj-Ali RA, et al.

American journal of ophthalmology 2021; (225()):172-177 doi:10.1016/j.ajo.2020.08.005.

Viral anterior uveitis.

Babu K, Konana VK, Ganesh SK, et al.

Indian journal of ophthalmology 2020; (68(9)):1764-1773 doi:10.4103/ijo.IJO_928_20.

Epidemiology of pediatric uveitis and associated systemic diseases.

Shin Y, Kang JM, Lee J, et al.

Pediatric rheumatology online journal 2021; (19(1)):48 doi:10.1186/s12969-021-00516-2.

Relevance of Brain MRI in Patients with Uveitis: Retrospective Cohort on 402 Patients.

Chirpaz NM, Kerever SMP, Gavoille AM, et al.

Ocular immunology and inflammation 2022; (30(5)):1109-1115 doi:10.1080/09273948.2020.1870145.

Classification Criteria for Sarcoidosis-Associated Uveitis.

American journal of ophthalmology 2021; (228()):220-230 doi:10.1016/j.ajo.2021.03.047.

Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis.

American journal of ophthalmology 2021; (228()):72-79 doi:10.1016/j.ajo.2021.03.044.

Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings.

Takeuchi M, Mizuki N, Ohno S

Frontiers in immunology 2021; (12()):640473 doi:10.3389/fimmu.2021.640473.

Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review.

Anderson WJ, da Cruz NFS, Lima LH, et al.

International journal of retina and vitreous 2021; (7(1)):37 doi:10.1186/s40942-021-00307-7.

The Clinical Spectrum and Outcome of Uveomeningitis: A Comprehensive Analysis of 110 Cases.

Hadjadj J, Gaube G, Groh M, et al.

Ocular immunology and inflammation 2022; (30(6)):1489-1494 doi:10.1080/09273948.2021.1898000.

Pediatric uveitis: A comprehensive review.

Maleki A, Anesi SD, Look-Why S, et al.

Survey of ophthalmology 2022; (67(2)):510-529 doi:10.1016/j.survophthal.2021.06.006.

CD4+ T-Cell Plasticity in Non-Infectious Retinal Inflammatory Disease.

Chen YH, Lightman S, Calder VL

International journal of molecular sciences 2021; (22(17)) doi:10.3390/ijms22179584.

Efficacy and Safety of Immunosuppressant Therapy for Noninfectious Uveitis: A Systematic Review and Meta-Analysis.

Zuo H, Zhang W, Yan Y

Computational and mathematical methods in medicine 2021; (2021()):1933604 doi:10.1155/2021/1933604.

The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies.

Xiong A, Liu D, Chen H, et al.

Frontiers in pharmacology 2021; (12()):620340 doi:10.3389/fphar.2021.620340.

The Association Between Mental Health Disorders and Non-Infectious Scleritis: A Prevalence Study and Review of the Literature.

Abdel-Aty A, Kombo N

European journal of ophthalmology 2022; (32(4)):1850-1856 doi:10.1177/11206721211067652.

Bartonella henselae-associated recurrent, bilateral segmental periphlebitis.

Ng CC, Ng J, McDonald HR, Cunningham ET

American journal of ophthalmology case reports 2022; (26()):101475 doi:10.1016/j.ajoc.2022.101475.

Progress in the genetics of uveitis.

Huang XF, Brown MA

Genes and immunity 2022; (23(2)):57-65 doi:10.1038/s41435-022-00168-6.

The Conundrum of Clinical Trials for the Uveitides: Appropriate Outcome Measures for One Treatment Used in Several Diseases.

Jabs DA, Berkenstock MK, Altaweel MM, et al.

Epidemiologic reviews 2022; (44(1)):2-16 doi:10.1093/epirev/mxac001.

The prevalence of anxiety symptoms and disorders among ophthalmic disease patients.

Ulhaq ZS, Soraya GV, Dewi NA, Wulandari LR

Therapeutic advances in ophthalmology 2022; (14()):25158414221090100 doi:10.1177/25158414221090100.

Sarcoid Uveitis: An Intriguing Challenger.

Allegri P, Olivari S, Rissotto F, Rissotto R

Medicina (Kaunas, Lithuania) 2022; (58(7)) doi:10.3390/medicina58070898.

Update on the systemic management of noninfectious uveitis in children and adolescents.

Leal I, Steeples LR, Wong SW, et al.

Survey of ophthalmology 2024; (69(1)):103-121 doi:10.1016/j.survophthal.2023.01.002.

Syphilitic Outer Retinopathy: A Case Report and Review of the Literature.

Amaral C, Joy L, Jimenez H, et al.

Journal of vitreoretinal diseases 2022; (6(1)):63-70 doi:10.1177/24741264211018300.

Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis.

Teabagy S, Wood E, Bilsbury E, et al.

Advanced drug delivery reviews 2023; (198()):114869 doi:10.1016/j.addr.2023.114869.

Frequency and Treatment Regimens of Macular Edema in 1946 Consecutive Patients with Noninfectious Uveitis at a Tertiary Ophthalmic Center in Shaanxi, China.

Xue YQ, Xiao JA, Chen Y

Ophthalmology and therapy 2023; (12(5)):2609-2619 doi:10.1007/s40123-023-00763-4.

Adamantiades-Behçet disease: Between dermatology and ophthalmology.

Grzybowski A, Pawlikowska-Łagód K, Altenburg A, Zouboulis CC

Clinics in dermatology 2023; (41(4)):469-475 doi:10.1016/j.clindermatol.2023.08.001.

Psychosocial Well-Being and Quality of Life in Uveitis: A Review.

Zhang Z, Griva K, Rojas-Carabali W, et al.

Ocular immunology and inflammation 2024; (32(7)):1380-1394 doi:10.1080/09273948.2023.2247077.

The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India.

Biswas J, Tyagi M, Agarwal M,

Ophthalmology science 2024; (4(1)):100403 doi:10.1016/j.xops.2023.100403.

Severe Intraocular Inflammation Following Intravitreal Faricimab.

Thangamathesvaran L, Kong J, Bressler SB, et al.

JAMA ophthalmology 2024; (142(4)):365-370 doi:10.1001/jamaophthalmol.2024.0530.

Characteristics of ocular hypertension and uveitic glaucoma among patients with noninfectious uveitis.

Felfeli T, Rhee J, Eshtiaghi A, et al.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2024; (59(6)):430-438 doi:10.1016/j.jcjo.2024.02.003.

Association of Fuchs Heterochromic Iridocyclitis with Multiple Sclerosis.

Brichová M, Lízrová JP, Heissigerová J, et al.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 2024; (80(4)):188-192 doi:10.31348/2024/17.

Long-term outcomes of noninfectious uveitis treated with systemic immunomodulatory therapy: a retrospective case series.

Felfeli T, Balas M, Tai F, et al.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2025; (60(1)):e133-e143 doi:10.1016/j.jcjo.2024.05.005.

Characterizing autoimmune uveitis to systemic diseases: a retrospective study from a Syrian tertiary reference center.

Kudsi M, Al-Darwish L, Khalayli N, et al.

Annals of medicine and surgery (2012) 2024; (86(7)):3929-3935 doi:10.1097/MS9.0000000000002054.

Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis.

Quinn J, Salman A, Paluch C, et al.

Scientific reports 2024; (14(1)):20033 doi:10.1038/s41598-024-68401-y.

Development of a Consensus Guideline for the Diagnosis and Management of Chronic Noninfectious Uveitis Affecting the Posterior Segment.

Singh RP, Albini TA, Baumal CR, et al.

Ophthalmic surgery, lasers & imaging retina 2024; (55(11)):652-658 doi:10.3928/23258160-20240625-01.

Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.

Saboya-Galindo P, Mejía-Salgado G, Cifuentes-González C, et al.

PloS one 2024; (19(10)):e0307455 doi:10.1371/journal.pone.0307455.

Uveitis among people with multiple sclerosis: A systematic review and meta-analysis.

Vaheb S, Yazdan Panah M, Shaygannejad V, et al.

Survey of ophthalmology 2025; (70(2)):331-338 doi:10.1016/j.survophthal.2024.11.002.

Axial Spondyloarthritis: A Review.

Bittar M, Deodhar A

JAMA 2025; (333(5)):408-420 doi:10.1001/jama.2024.20917.

Endophthalmitis caused by Enterococcus faecalis: cytological and bacteriological diagnosis using vitreous fluid.

Ramtohul P, Frankel D, Gouriet F, et al.

Journal of ophthalmic inflammation and infection 2025; (15(1)):22 doi:10.1186/s12348-025-00482-w.

Noninfectious Uveitis in Pediatric Rheumatology: Long-term Follow-up at Tertiary Centers.

Akay N, Gul U, Koker O, et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2025; (31(5)):181-187 doi:10.1097/RHU.0000000000002220.

Programme for ocular inflammation & infection translational research (PROTON) registry: Cross-sectional analysis of baseline patient characteristics.

Rojas-Carabali W, Chan K, Cifuentes-Gonzalez C, et al.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2025; (14(3)):100199 doi:10.1016/j.apjo.2025.100199.

Uveitis in Adults: A Review.

Maghsoudlou P, Epps SJ, Guly CM, Dick AD

JAMA 2025; (334(5)):419-434 doi:10.1001/jama.2025.4358.

Etiology and Anatomical Location of Uveitis-Prognostic Factors for Disease Course and Laterality.

Mitkova-Hristova VT, Atanassov MA

Life (Basel, Switzerland) 2025; (15(6)) doi:10.3390/life15060882.

Inflammatory bowel disease does not confer higher disease activity or greater radiographic progression in axial spondyloarthritis.

Remalante-Rayco P, Daghistani Y, Chim T, et al.

Rheumatology (Oxford, England) 2025; (64(12)):6302-6308 doi:10.1093/rheumatology/keaf420.

Clinical Features of Behçet's Disease Uveitis.

Yalçindag N, Oklar M

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2025; (39(4)):290-298 doi:10.4103/sjopt.sjopt_163_24.

Ten-Year Registry Analysis of Ocular Inflammation in Taiwan: Distinct Clinical Patterns and Systemic Associations in Adults and Children.

Sun WH, Wang LU, Wang JK, et al.

Ocular immunology and inflammation 2026; (34(2)):325-333 doi:10.1080/09273948.2025.2607621.

Low-volume multiplex solid-phase PCR without DNA extraction for etiological diagnosis of infectious uveitis.

Ferracioli-Oda E, Tanaka T, Gouvea MSG, et al.

Indian journal of ophthalmology 2026; (74(2)):234-239 doi:10.4103/IJO.IJO_1135_25.

Risk of Glaucoma in Patients With Idiopathic Noninfectious Uveitis: A Multi-Institutional Real-World Retrospective Cohort Study.

Liu DY, Kuo HT, Hsu AY, et al.

American journal of ophthalmology 2026; (285()):63-72 doi:10.1016/j.ajo.2026.01.020.

Adalimumab, Anakinra, and Tocilizumab in Patients With Noninfectious Uveitis: A Multicenter Randomized Controlled Trial.

Saadoun D, Ghembaza A, Touhami S, et al.

American journal of ophthalmology 2026; (285()):202-212 doi:10.1016/j.ajo.2026.01.037.

Current perspective on infectious uveitis.

Gupta A

Indian journal of ophthalmology 2026; (74(6)):798-803 doi:10.4103/IJO.IJO_3289_25.

Immunology of Uveitis - From Bench to Bedside.

Wildner G, Thurau S

Klinische Monatsblatter fur Augenheilkunde 2026; (243(5)):571-583 doi:10.1055/a-2730-1076.

Patterns of Inflammation in Experimental Autoimmune Uveitis and Their Correlation to Optical Coherence Tomography Findings in Human Uveitis.

Schworm B, Ghannoum T, Thurau S, Wildner G

International journal of molecular sciences 2026; (27(4)) doi:10.3390/ijms27041618.

Medication adherence rates in patients with ocular inflammatory disease.

Chew ZRJ, Cheng LC, Agrawal R, et al.

Frontiers in medicine 2026; (13()):1745392 doi:10.3389/fmed.2026.1745392.

Post-Visual Diagnosis Distress: The Weight of Threatened Sight.

Aslam TM, Ziemssen F, Loewenstein A, et al.

Ophthalmology and therapy 2026; (15(5)):1555-1559 doi:10.1007/s40123-026-01362-9.

Noninfectious uveitis: Management with biologic agents.

Rathinam SR, Anjana S

Indian journal of ophthalmology 2026; (74(6)):837-844 doi:10.4103/IJO.IJO_3239_25.

Eye-brain axis: Ocular and visual pathophysiology as driver and therapeutic target across the mood disorder trajectory.

Zhang X, Wang X, Zhu H, et al.

Progress in retinal and eye research 2026; (112()):101467 doi:10.1016/j.preteyeres.2026.101467.

Systemic and ocular complications related to intravitreal administration of anti-VEGF agents.

Koksaldi S, Kayabasi M, Karti O, Saatci AO

Medical hypothesis, discovery & innovation ophthalmology journal 2026; (15(1)):40-68 doi:10.51329/mehdiophthal1539.

Immune Privilege of the Eye: A Delicate Balance Between Clarity and Chaos.

Prieto-Nevárez HM, Tarango-García A, Ollivier-Valenzuela LI, et al.

Ocular immunology and inflammation 2026; (34(5)):1143-1155 doi:10.1080/09273948.2026.2677099.

Baseline OCT biomarkers associated with visual prognosis in cystoid macular edema secondary to noninfectious uveitis.

Bodur MF, Koçak N, Eser-Ozturk H, Sullu Y

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2026; doi:10.1007/s00417-026-07292-3.

Immune checkpoint inhibitor-associated uveitis in metastatic melanoma: case report and literature review.

Akcay P, Esen Baris M, Güven S, et al.

Melanoma research 2026; (36(4)):314-320 doi:10.1097/CMR.0000000000001112.

Adalimumab Reprograms M1 Macrophages to Attenuate Th1/Th17 Responses in Behçet's Uveitis and Vogt-Koyanagi-Harada Syndrome.

Zhu Y, Yu Q, Ma Y, et al.

Investigative ophthalmology & visual science 2026; (67(6)):4 doi:10.1167/iovs.67.6.4.

Blood-Ocular Barrier Dysfunction in Uveitis: A Bidirectional Model Linking Pathogenesis, Clinical Monitoring, and Therapeutic Opportunities.

Chen Y, Yang M, Zou Y, et al.

Medical sciences (Basel, Switzerland) 2026; (14(2)) doi:10.3390/medsci14020290.